JASON ERIKSEN to Alzheimer Disease
This is a "connection" page, showing publications JASON ERIKSEN has written about Alzheimer Disease.
Connection Strength
1.474
-
Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener. 2014 Nov 28; 9:54.
Score: 0.262
-
Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory. Neurosci Lett. 2013 Aug 26; 548:296-300.
Score: 0.237
-
Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet. 2007 Jan; 37(1):79-100.
Score: 0.150
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.111
-
1-Indanone and 1,3-indandione Derivatives as Ligands for Misfolded a-Synuclein Aggregates. ChemMedChem. 2022 01 19; 17(2):e202100611.
Score: 0.106
-
Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress. Am J Physiol Heart Circ Physiol. 2020 06 01; 318(6):H1559-H1569.
Score: 0.096
-
Regular exercise prevents non-cognitive disturbances in a rat model of Alzheimer's disease. Int J Neuropsychopharmacol. 2014 Apr; 17(4):593-602.
Score: 0.061
-
A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease. J Neurochem. 2014 Feb; 128(3):419-30.
Score: 0.061
-
Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Curr Alzheimer Res. 2013 06; 10(5):507-15.
Score: 0.059
-
Inhibitory neuron and hippocampal circuit dysfunction in an aged mouse model of Alzheimer's disease. PLoS One. 2013; 8(5):e64318.
Score: 0.059
-
Intravenous delivery of targeted liposomes to amyloid-? pathology in APP/PSEN1 transgenic mice. PLoS One. 2012; 7(10):e48515.
Score: 0.057
-
NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol Sci. 2007 Oct; 28(10):536-43.
Score: 0.040
-
Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neurosci. 2007 Jul 24; 8:54.
Score: 0.039
-
A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 2006 May; 22(5):281-9.
Score: 0.036
-
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med. 2005 May; 11(5):545-50.
Score: 0.034
-
NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest. 2003 Aug; 112(3):440-9.
Score: 0.030
-
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001 Nov 08; 414(6860):212-6.
Score: 0.027
-
Substrate-targeting gamma-secretase modulators. Nature. 2008 Jun 12; 453(7197):925-9.
Score: 0.010